These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 14532989
1. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin. Kamuhabwa AA, Huygens A, De Witte PA. Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989 [Abstract] [Full Text] [Related]
3. Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation. Huygens A, Kamuhabwa AR, Van Laethem A, Roskams T, Van Cleynenbreugel B, Van Poppel H, Agostinis P, De Witte PA. Int J Oncol; 2005 Jun; 26(6):1691-7. PubMed ID: 15870887 [Abstract] [Full Text] [Related]
4. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors. Zupkó I, Kamuhabwa AR, D'Hallewin MA, Baert L, De Witte PA. Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062 [Abstract] [Full Text] [Related]
5. Photodynamic activity of hypericin in human urinary bladder carcinoma cells. Kamuhabwa AR, Agostinis P, D'Hallewin MA, Kasran A, de Witte PA. Anticancer Res; 2000 May; 20(4):2579-84. PubMed ID: 10953329 [Abstract] [Full Text] [Related]
7. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma. Bhuvaneswari R, Gan YY, Yee KK, Soo KC, Olivo M. Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271 [Abstract] [Full Text] [Related]
8. Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells. Huygens A, Kamuhabwa AR, Roskams T, VAN Cleynenbreugel B, VAN Poppel H, de Witte PA. J Urol; 2005 Jul; 174(1):69-72. PubMed ID: 15947580 [Abstract] [Full Text] [Related]
9. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model. Du HY, Bay BH, Olivo M. Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667 [Abstract] [Full Text] [Related]
13. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. Höpfner M, Maaser K, Theiss A, Lenz M, Sutter AP, Kashtan H, von Lampe B, Riecken EO, Zeitz M, Scherübl H. Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490 [Abstract] [Full Text] [Related]
14. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Buytaert E, Matroule JY, Durinck S, Close P, Kocanova S, Vandenheede JR, de Witte PA, Piette J, Agostinis P. Oncogene; 2008 Mar 20; 27(13):1916-29. PubMed ID: 17952126 [Abstract] [Full Text] [Related]
15. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT. Thong PS, Watt F, Ren MQ, Tan PH, Soo KC, Olivo M. J Photochem Photobiol B; 2006 Jan 02; 82(1):1-8. PubMed ID: 16203156 [Abstract] [Full Text] [Related]
16. Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines. Ritz R, Wein HT, Dietz K, Schenk M, Roser F, Tatagiba M, Strauss WS. Int J Oncol; 2007 Mar 02; 30(3):659-67. PubMed ID: 17273767 [Abstract] [Full Text] [Related]
17. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells. Wang X, Guo Y, Yang S, Wang C, Fu X, Wang J, Mao Y, Zhang J, Li Y. J Pharmacol Exp Ther; 2010 Sep 01; 334(3):847-53. PubMed ID: 20551295 [Abstract] [Full Text] [Related]